INDIANAPOLIS (dpa-AFX) - Corgenix Medical Corp. (CONX.OB) announced that it has entered into a collaboration agreement with Eli Lilly and Co.(LLY) to develop diagnostic technology in support of a Lilly oncology pipeline program.
As per the terms of the agreement, the two companies will collaborate to further advance this proprietary diagnostic technology originally developed by Lilly. The financial terms of the agreement were not disclosed.
The collaboration with Lilly is part of Corgenix' recently announced expansion of its Contract Services Business Unit for contract product development, technology application and manufacturing for the healthcare and biotechnology industries, Corgenix said.
Copyright RTT News/dpa-AFX
© 2013 AFX News
